Sunday March 24, 2019
|
Subscribe
|
Contribute
|
About
|
Access Your Account
|
Register
|
Login
Home
#46142 (no title)
Analytical, Formulation and Quality
Cell Culture & Upstream Processing
Drug Product Manufacturing & Fill-Finish Processing
Early Stage Biologics and Companies
Manufacturing Strategy
Podcast Sponsors
Charter Medical
Fujifilm Diosynth Biotechnologies
Gyros
ILC Dover
Pall Life Sciences
Recovery & Purification
#60015 (no title)
Cell Culture & Upstream Processing
Recovery & Purification
Bioprocessing 4.0 – The Path to Smart Manufacturing
Analytical & Quality
Speed from Gene to Market
2018 BioProcess International Conference & Exhibition Pre-Event Planner
2014-07-10 PDF test 01
2016 BioProcess International Awards
Best Collaboration Finalists – 2016 BioProcess International Awards
Best Technology Application – ANALYTICAL Finalists
Best Technology Application – DOWNSTREAM Finalists
Best Technology Application – UPSTREAM Finalists
Corporate Citizenship Award Finalists – 2016 BioProcess International Awards
Emerging Company Finalists – 2016 BioProcess International Awards
Excellence in Facility Design or Retrofit Finalists – 2016 BioProcess International Awards
Excellence in Leadership Award Finalists – 2016 BioProcess International Awards
FAQs: BioProcess International 2016 Awards
Past Winners of BioProcess International Awards
A New Paradigm in Process Development: To Accelerate Biologic Manufacturing of MAbs, Vaccines, and Novel Biotherapies
Addressing High Demands for Increased Productivity in Downstream Operations
Advances in Single-Use Platforms for Commercial Manufacturing
April 2018 – Smart(er) Facilities: Automation and Innovation Can Take Bioprocessing to the Next Level of Intelligence
Biopharmaceutical Training Supplement
Bioreactors: Process Advances in Cell Culture and Fermentation
BPI Conf Home
Cookie Policy
eBooks
Events
Featured Reports
Industry Innovators: 2018-2019
Upstream Processing — Industry Innovators: 2018-2019
Downstream Processing — Industry Innovators 2018-2019
Manufacturing — Industry Innovators 2018-2019
Analytical Methods and Instrumentation — Industry Innovators 2018-2019
Issue Archive
2018 Archive
2017 Archive
2016 Archive
2015 Archive
2014 Archive
2013 Archive
2012 Archive
2011 Archive
2010 Archive
2009 Archive
2008 Archive
2007 Archive
2006 Archive
2005 Archive
2004 Archive
2003 Archive
January-February 2019 Featured Report
March 2019 Featured Report: Addressing Challenges in Formulation
May 2017 Featured Report: Continuous Processes – Disposables Integrate Upstream and Downstream Processing
November 2018 Featured Report: The Biopharmaceutical Supply Chain
October 2018 Featured Report: Bioassays
Roundtables
September 2018 Featured Report: Cell Line Development
State of the Industry – 2017 BioProcess International Special Issue
The Regulatory Affairs Perspective: Addressing Compliance in a Changing Industry – Chapter 5
The Supply-Chain Management Perspective: Managing Risks and Guarding Against Disruption – Chapter 6
The Bioexecutive Perspective: Business Strategies for a Rapidly Maturing Industry – Chapter 1
The Laboratory Manager’s Perspective: Ensuring Efficiency, Data Integrity, and Compliance
The Project Manager’s Perspective: Managing Timelines, Budgets, and Milestones in Multidisciplinary Teams – Chapter 3
The R&D Perspective: Mapping New Pathways from Discovery to Development – Chapter 4
The Process Development Perspective: Implementing Tools for Optimization – Chapter 7
The Manufacturing Perspective: Current Approaches to Bioprocess Intensification – Chapter 8
The Technology Transfer Perspective: Modern Approaches and Challenges – Chapter 9
The Engineer’s Perspective: Transforming Science into Technology – Chapter 10
The Analyst’s Perspective: Ensuring and Controlling Quality of Well-Characterized Biologics – Chapter 11
About
Who We Are
Management Team
Editorial Advisors
Author Guidelines
Article Submission Details
House Style and Copy-Editing Practices
Submitting Graphics
(Photos and Figures) to BPI
Advertising/Media Kit
List Rental/Reprints
Contact Us
Careers
BPA Statement
Awards
Resources
Register
Registration Successful
Contribute
Download PDF
Email Newsletters
Subscribe
Account
Privacy Policy
Site Map
Covering the whole development process for the global biotechnology industry
Upstream
Processing
Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
Assays
Biochemicals/Raw Materials
Bioreactors
Cell Culture Media
Expression Platforms
Fermentation
Perfusion Cell Culture
Upstream Contract Services
Upstream Single-Use Technologies
Downstream
Processing
Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
Filtration
Separation/Purification
Viral Clearance
Chromatography
Downstream Contract Services
Downstream Single-Use Technologies
Manufacturing
Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
Personalized Medicine
Single Use
Supply Chain
Vaccines
MAb
Biosimilars
Cell Therapies
Emerging Therapeutics
Facility Design/Engineering
Continuous Bioprocessing
Fill/Finish
Formulation
Information Technology
Manufacturing Contract Services
Process Monitoring and Controls
Analytical
Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
Culture Development
Cell Line Development
Downstream Development
Downstream Validation
Laboratory Equipment
PAT
Pre-Formulation
Product Characterization
QA/QC
Upstream Development
Upstream Validation
Leachables/Extractables/Particulates
Business
Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
Careers
CMC Forums
Economics
Intellectual Property
Pre-Clinical and Clinical Trials
Regulatory Affairs
Risk Management
BioRegions
Monday, September 1, 2003
Daily Archives
What Are the Options?
by
BPI Contributor
Euro TIDES 2003
by
BPI Contributor
Drug Pricing Principles
by
BPI Contributor
Conferences, Courses, and Events
by
BPI Contributor
Computer Validation Basics
by
BPI Contributor
Characterization of Alternatives to Animal-Derived Raw Materials
by
BPI Contributor
Characteristics of a Good Antibody Manufacturing Process
by
BPI Contributor
Bringing Together Software Audit Data for Regulatory Compliance
by
BPI Contributor
BPI Reports
by
BPI Contributor
An Overview of the Japanese Biotechnology Industry
by
BPI Contributor
1
2
3
>
Home
Current Issue
Issue Archive
▼
Featured Reports
eBooks
BioProcess Insider
Multimedia
▼
BPI White Papers
Webinars
Posters
BioProcess International Events
Events
